After spectacularly failing to beat Sans, you’ll find yourself in the Void, with the mission to reclaim your determination and get your true soul back from Gaster. Learn abilities from various beloved ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE ® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results